Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset.

Puthenparampil M, Zito A, Pantano G, Federle L, Stropparo E, Miante S, De Silvestro G, Plebani M, Gallo P.

Mult Scler. 2018 Jun 1:1352458518779951. doi: 10.1177/1352458518779951. [Epub ahead of print]

PMID:
29882478
2.

Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenon.

Puthenparampil M, Rinaldi F, Federle L, Cazzola C, Perini P, Gallo P.

Ther Adv Neurol Disord. 2017 Nov 29;11:1756285617741056. doi: 10.1177/1756285617741056. eCollection 2018.

3.

Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy.

Rinaldi F, Federle L, Puthenparampil M, Perini P, Grassivaro F, Gallo P.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 13;5(1):e420. doi: 10.1212/NXI.0000000000000420. eCollection 2018 Jan. No abstract available.

4.

A new T2 lesion in a patient with the clinically isolated syndrome does not necessarily imply a conversion to multiple sclerosis.

Capone F, Puthenparampil M, Mallio CA, Celia AI, Florio L, Gallo P, Di Lazzaro V.

Clin Neurol Neurosurg. 2018 Jan;164:138-141. doi: 10.1016/j.clineuro.2017.12.009. Epub 2017 Dec 7.

PMID:
29223794
5.

Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis.

Puthenparampil M, Federle L, Poggiali D, Miante S, Signori A, Pilotto E, Rinaldi F, Perini P, Sormani MP, Midena E, Gallo P.

PLoS One. 2017 Aug 29;12(8):e0183957. doi: 10.1371/journal.pone.0183957. eCollection 2017.

6.

Acute simultaneous development of brain tumour-like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitis.

Puthenparampil M, Terrin A, Federle L, Gizzi M, Perini P, Gallo P.

Mult Scler. 2018 Apr;24(4):546-550. doi: 10.1177/1352458517714610. Epub 2017 Aug 10.

PMID:
28795610
7.

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.

Gaiani A, Martinelli I, Bello L, Querin G, Puthenparampil M, Ruggero S, Toffanin E, Cagnin A, Briani C, Pegoraro E, Sorar├╣ G.

JAMA Neurol. 2017 May 1;74(5):525-532. doi: 10.1001/jamaneurol.2016.5398.

8.

BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.

Puthenparampil M, Federle L, Miante S, Zito A, Toffanin E, Ruggero S, Ermani M, Pravato S, Poggiali D, Perini P, Rinaldi F, Gallo P.

J Neuroinflammation. 2017 Jan 17;14(1):11. doi: 10.1186/s12974-016-0785-2.

9.

BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset.

Puthenparampil M, Miante S, Federle L, Zanetta C, Toffanin E, Ruggero S, Rinaldi F, Gallo P.

J Neuroimmunol. 2016 Aug 15;297:63-7. doi: 10.1016/j.jneuroim.2016.05.013. Epub 2016 May 16.

PMID:
27397077
10.

Cortical relapses in multiple sclerosis.

Puthenparampil M, Poggiali D, Causin F, Rolma G, Rinaldi F, Perini P, Gallo P.

Mult Scler. 2016 Aug;22(9):1184-91. doi: 10.1177/1352458514564483. Epub 2015 Mar 19.

PMID:
25791367
11.

Cerebrospinal fluid IL-1╬▓ correlates with cortical pathology load in multiple sclerosis at clinical onset.

Seppi D, Puthenparampil M, Federle L, Ruggero S, Toffanin E, Rinaldi F, Perini P, Gallo P.

J Neuroimmunol. 2014 May 15;270(1-2):56-60. doi: 10.1016/j.jneuroim.2014.02.014. Epub 2014 Mar 6.

PMID:
24657029
12.

Increased incidence of multiple sclerosis in the Veneto region, Italy.

Puthenparampil M, Seppi D, Rinaldi F, Federle L, Calabrese M, Perini P, Gallo P; Multiple Sclerosis Epidemiology Veneto Study Group (MuSEV).

Mult Scler. 2013 Apr;19(5):601-4. doi: 10.1177/1352458512461970.

PMID:
23599184
13.

Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.

Rinaldi F, Calabrese M, Seppi D, Puthenparampil M, Perini P, Gallo P.

Mult Scler. 2012 Dec;18(12):1760-7. doi: 10.1177/1352458512447704. Epub 2012 May 8.

PMID:
22570359
14.

Cortical lesions and cognitive impairment in multiple sclerosis.

Rinaldi F, Calabrese M, Grossi P, Puthenparampil M, Perini P, Gallo P.

Neurol Sci. 2010 Nov;31(Suppl 2):S235-7. doi: 10.1007/s10072-010-0368-4. Review.

PMID:
20635113
15.

Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report.

Rinaldi F, Calabrese M, Seppi D, Puthenparampil M, Perini P, Gallo P.

Neurol Sci. 2011 Jan;31 Suppl 3:317-20. doi: 10.1007/s10072-010-0346-x.

PMID:
20535514

Supplemental Content

Loading ...
Support Center